There are two things.
First is more money, as always. Let's face it. We're talking about having to support that research. I think it's great to see that the provinces are willing to invest with us in this area, that they recognize the importance of a better evaluation, and a constant evaluation, of not only new treatments but also current treatments and practices.
Second is the people to do that type of research. We don't have enough clinical investigators. Their time is not protected. Their salary is not supported. We don't have enough implementation researchers. We don't have enough health economists. We don't have enough biostatisticians in this country. We have to train these people. This is a type of researcher that we haven't trained enough of.
That's what we're pushing for with our partners in the universities, in the academic health centres.